Eye2Gene is a UCL spinout delivering an end-to-end AI-powered precision ophthalmology platform for inherited retinal diseases. Integrating retinal imaging with genomics, the platform optimises the full pharma life cycle, from predictive screening and diagnostic variant prioritisation to longitudinal monitoring, saving critical time and costs to bring therapies and diagnostics faster to patients.
Eye2Gene Ltd
Category
- Industry and industry bodies
Functions
- Clinical trial development and participant recruitment
- Digital Innovation
- Healthcare delivery
